Profound Medical Corp. (PROF): Total Assets
$77.47M
As of 2025-12-31
$62.38M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $77.47M | +10.3% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $70.23M | +59.8% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $43.96M | n/a | 2025-03-07, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Profound Medical Corp. (PROF) | 2025-12-31 | $77.47M | +10.3% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $6.45M | +14.3% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $15.77M | -51.9% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $25.15M | +64.6% |
| Nephros Inc (NEPH) | 2025-12-31 | $13.64M | +21.7% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $13.96M | +1.9% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | $21.41M | +77.0% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $110.08M | -7.4% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $69.70M | -10.6% |
Compare PROF, BTCY, ALUR, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗